Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of ERG mRNA | affects expression | 21346803
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of ERG mRNA | decreases expression | 18648102
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of ERG mRNA | affects expression | 16483693
|
D000728 |
Androgens |
Androgens promotes the reaction [TOP2B protein results in increased mutagenesis of ERG gene] | increases mutagenesis|increases reaction | 20601956
|
D003520 |
Cyclophosphamide |
Cyclophosphamide results in increased expression of ERG mRNA | increases expression | 17403535
|
C014347 |
decitabine |
decitabine results in decreased methylation of ERG promoter alternative form | decreases methylation | 19108891
|
C014347 |
decitabine |
decitabine results in increased expression of ERG mRNA | increases expression | 19194470
|
C014347 |
decitabine |
decitabine results in increased expression of ERG mRNA alternative form | increases expression | 19108891
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of ERG mRNA | decreases expression | 18035473
|
C065180 |
fluvastatin |
[zoledronic acid co-treated with fluvastatin] results in increased expression of ERG mRNA | affects cotreatment|increases expression | 16996129
|
D020366 |
Methylmethacrylate |
Methylmethacrylate results in increased expression of ERG mRNA | increases expression | 16916219
|
C016766 |
sulforafan |
sulforafan inhibits the reaction [AR protein binds to ERG enhancer] | affects binding|decreases reaction | 19805354
|
C016766 |
sulforafan |
sulforafan results in decreased expression of ERG mRNA | decreases expression | 19805354
|
C016766 |
sulforafan |
sulforafan results in decreased expression of ERG protein | decreases expression | 19805354
|
D014028 |
Tobacco Smoke Pollution |
Tobacco Smoke Pollution results in increased expression of ERG mRNA | increases expression | 18087596
|
C012589 |
trichostatin A |
trichostatin A results in decreased expression of ERG mRNA | decreases expression | 19805354
|
C025643 |
vinclozolin |
vinclozolin affects the expression of ERG mRNA | affects expression | 19015723
|
C088658 |
zoledronic acid |
[zoledronic acid co-treated with fluvastatin] results in increased expression of ERG mRNA | affects cotreatment|increases expression | 16996129
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.64 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
zoledronic acid |
4.51 | 19715164 |
MESH:D000210 |
Acute-Phase Reaction |
|
zoledronic acid |
5.56 | 20200999 |
MESH:D002282 |
Adenocarcinoma, Bronchiolo-Alveolar |
|
Tobacco Smoke Pollution |
5.63 | 15814487 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.78 | 3712494 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
sulforafan |
5.32 | 17942926 |
MESH:D000544 |
Alzheimer Disease |
|
Androgens |
3.62 | 17917157 17182789 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.68 | 19015723 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
4.67 | 15014928 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tobacco Smoke Pollution |
3.19 | 19898480 |
MESH:D001327 |
Autoimmune Diseases |
|
sulforafan |
5.65 | 19761891 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.12 | 11289319 1440618 |
MESH:D001859 |
Bone Neoplasms |
|
zoledronic acid |
5.02 | 16121404 16778634 19442620 15867366 11697798 17312309 |
MESH:D001862 |
Bone Resorption |
|
zoledronic acid |
4.76 | 8053405 11869084 16769263 18404659 15845617 18496637 |
MESH:D001943 |
Breast Neoplasms |
|
Androgens |
2.15 | 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
2.15 | 16978400 11325840 15093573 17388661 17020986 18323546 15136595 18234424 12006526 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.15 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
zoledronic acid |
2.15 | 16096432 18695136 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
4.72 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
4.72 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
4.72 | 19701751 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
4.97 | 16152834 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Tobacco Smoke Pollution |
6.19 | 11212258 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
zoledronic acid |
6.19 | 19233551 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
11.09 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
11.09 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
zoledronic acid |
11.09 | 18507039 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
5.15 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tobacco Smoke Pollution |
5.15 | 11212258 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
6.78 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
6.78 | 7505956 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
3.19 | 9022650 19486331 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.34 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D003327 |
Coronary Disease |
|
fluvastatin |
4.84 | 16142594 |
MESH:D016638 |
Critical Illness |
|
Androgens |
6.14 | 16670151 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.41 | 14966744 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.09 | 18551238 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
5.08 | 17979934 16413132 12161096 10498854 11948286 15276878 18483878 15643279 10700343 16614059 16989017 12388444 18295254 12913760 18372110 18093676 18433785 18710439 16651033 17010015 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.87 | 11906362 2524372 11298694 14531868 8970840 8156756 12868966 18759878 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.55 | 2952479 3621924 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
4.11 | 15331540 11751995 10990075 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.23 | 18772604 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
3.90 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
3.90 | 9328219 1440618 18692083 16192314 8291058 18289764 7440962 11289319 18648102 6482804 9653073 6679447 9022650 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
14.36 | 19294695 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
14.36 | 19294695 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.29 | 11006010 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.12 | 3581430 |
MESH:D005264 |
Femoral Fractures |
|
zoledronic acid |
5.91 | 16234978 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.12 | 6705139 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.02 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.40 | 16417039 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
3.86 | 18801729 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.60 | 11389073 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.10 | 7505956 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
5.11 | 16376943 11014644 15172196 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.52 | 19215824 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.36 | 11918545 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.63 | 14986274 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.58 | 6705139 |
MESH:D006628 |
Hirsutism |
|
Androgens |
6.18 | 17019078 16914592 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
3.83 | 17606976 16135485 |
MESH:D006930 |
Hyperalgesia |
|
zoledronic acid |
4.29 | 16769263 |
MESH:D017588 |
Hyperandrogenism |
|
Androgens |
5.83 | 17019078 |
MESH:D006934 |
Hypercalcemia |
|
zoledronic acid |
5.10 | 19622757 18089816 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
4.01 | 15034207 |
MESH:D006996 |
Hypocalcemia |
|
zoledronic acid |
6.29 | 12669777 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.43 | 16076520 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
11.60 | 16517039 7193160 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
11.60 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
11.60 | 16467254 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
5.63 | 17296493 |
MESH:D007249 |
Inflammation |
|
Tobacco Smoke Pollution |
5.63 | 18590791 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.12 | 8074119 9022650 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.51 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.51 | 6582329 |
MESH:D007938 |
Leukemia |
marker/mechanism |
|
| 19108891 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
6.78 | 10602166 |
MESH:D007938 |
Leukemia |
|
decitabine |
6.78 | 19235587 18980019 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.52 | 18587576 17658394 17296974 17802794 18172266 17008537 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
zoledronic acid |
4.82 | 18089816 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
4.13 | 10373061 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.06 | 18454857 17236224 19117987 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
4.30 | 17679729 18704418 18460780 19387464 18206229 19010910 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
4.30 | 18206229 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.56 | 18055864 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
5.05 | 10052129 11830472 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.81 | 16417039 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.23 | 9327722 15034207 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
2.17 | 7678174 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
6.00 | 2876786 2876784 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
6.00 | 598648 1399818 3712494 6587162 |
MESH:D008175 |
Lung Neoplasms |
|
Tobacco Smoke Pollution |
2.72 | 3440675 11091918 16288123 12111688 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
7.99 | 12854902 |
MESH:D008223 |
Lymphoma |
|
decitabine |
7.99 | 19470736 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.65 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
4.21 | 11911406 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
zoledronic acid |
3.75 | 17312309 |
MESH:D008545 |
Melanoma |
|
decitabine |
3.75 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
3.75 | 16505122 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
4.87 | 16388313 |
MESH:D008654 |
Mesothelioma |
|
zoledronic acid |
3.77 | 16675582 |
MESH:D009062 |
Mouth Neoplasms |
|
Tobacco Smoke Pollution |
4.39 | 15006635 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
17.75 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
fluvastatin |
17.75 | 16996129 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
17.75 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
zoledronic acid |
17.75 | 19621390 16996129 18089719 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.41 | 16882708 19157545 18608210 19010910 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.94 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
6.16 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
zoledronic acid |
6.16 | 17312309 19139120 15867366 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
5.54 | 18854779 |
MESH:D009369 |
Neoplasms |
|
decitabine |
5.54 | 17925555 19116145 19470736 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
2.95 | 6679447 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
3.66 | 16115947 15176712 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.97 | 8761367 12837982 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.38 | 8291058 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.05 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
9.05 | 6482804 4026338 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.79 | 16517039 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.12 | 3988306 |
MESH:D010014 |
Osteolysis |
|
zoledronic acid |
5.45 | 15867366 |
MESH:D010024 |
Osteoporosis |
|
zoledronic acid |
4.06 | 17882678 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
5.32 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
5.32 | 19331143 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
7.57 | 18093676 12161096 |
MESH:D010146 |
Pain |
|
zoledronic acid |
7.57 | 16475674 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
8.97 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
8.97 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
8.97 | 19294695 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.55 | 7296757 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.57 | 6228378 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.83 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
3.98 | 18220299 18042343 19015723 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
12.67 | 17616702 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
12.67 | 17616702 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.02 | 18220299 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 19396168 17173048 18798265 |
MESH:D011471 |
Prostatic Neoplasms |
|
Androgens |
2.26 | 16998812 15389811 17909013 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.26 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
2.26 | 19789329 18798265 |
MESH:D011471 |
Prostatic Neoplasms |
|
zoledronic acid |
2.26 | 12438248 19103299 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.02 | 18629315 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.30 | 16636934 |
MESH:D012135 |
Respiratory Sounds |
|
Tobacco Smoke Pollution |
4.69 | 18410779 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.41 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.46 | 19155313 |
MESH:D012512 |
Sarcoma, Ewing's |
|
zoledronic acid |
5.00 | 16121404 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.88 | 16636934 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.57 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Tobacco Smoke Pollution |
3.55 | 18590791 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.60 | 16517039 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
5.14 | 12837982 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.38 | 6587162 6582329 1399818 7505956 3712494 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
7.38 | 17967635 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
16.06 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
16.06 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
16.06 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
16.06 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tobacco Smoke Pollution |
16.06 | 12846360 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.40 | 10091137 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.01 | 17785578 |